Concepedia

R. Somaratne

RS

Statistics

Publications

2

Citations

311

H-Index

2

Active since

2014

Affiliations

Texas Digestive Disease Consultants(Current)

R. Somaratne is an author at Texas Digestive Disease Consultants specializing in pharmacotherapy, pharmacology, and clinical pharmacology.

Publications per year

2014–2018

2

Publications

2

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

Gideon M. Hirschfield, Olivier Chazouillères, Joost P.H. Drenth et al. · Journal of Hepatology · 2018 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

Evan A. Stein, Robert P. Giugliano, Michael J. Koren et al. · European Heart Journal · 2014 · 131 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–2 of 2